Evidence map›Paper›PMID 35932362›Full record

ArticleHuman cell2022

MiR-223-3p-loaded exosomes from bronchoalveolar lavage fluid promote alveolar macrophage autophagy and reduce acute lung injury by inhibiting the expression of STK39.

Nan He, Haoyu Tan, Xueyu Deng, Lu Shu, Bei Qing, Hengxing Liang

Abstract read
PubMed Publisher
In one paragraph

Article in Human cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. 1-L Transcription of SARS-CoV-2 Spike Protein S1 Subunit.International journal of molecular sciences · 2024
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Nan HeCollege of Animal Science and Veterinary Medicine, Shandong Agricultural University, Tai-an, 271018, Shandong, People's Republic of China.
Haoyu TanDepartment of Cardio-Vascular Surgery, the Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, People's Republic of China.
Xueyu DengDepartment of Thoracic Surgery, the Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, People's Republic of China.
Lu ShuDepartment of Thoracic Surgery, the Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, People's Republic of China.
Bei QingDepartment of Thoracic Surgery, the Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, People's Republic of China.
Hengxing LiangDepartment of Thoracic Surgery, the Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, People's Republic of China. lianghengxing84@csu.edu.cn.
Central South University · CNSecond Xiangya Hospital of Central South University · CNShandong Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the molecular mechanism by which bronchoalveolar lavage fluid exosomes (BALF-exo) alleviated acute lung injury (ALI). BALF-exo was isolated from mice. LPS was used to induce inflammation in rat alveolar macrophages (NR8383). NR8383 cell models were treated with BALF-exo or BALF-exo loaded with miR-223-3p mimics/inhibitors, or STK39 was overexpressed in NR8383 cells before LPS and BALF-exo treatment. These cells were subjected to apoptosis, autophagy, and inflammation assays. RNA immunoprecipitation and dual-luciferase reporter assay were conducted to verify the binding between miR-223-3p and STK39. LPS-induced ALI mouse models were treated with BALF-exo loaded with miR-223-3p mimics. miR-223-3p was lowly expressed in BALF-exo from LPS-treated mice. BALF-exo loaded with miR-223-3p mimics increased viability and autophagy and decreased apoptosis and inflammation in NR8383 cell models. Inhibition of miR-223-3p in BALF-exo or overexpression of STK39 in NR8383 cells repressed the therapeutic effect of BALF-exo in LPS-treated NR8383 cells. STK39 was a target gene of miR-223-3p. miR-223-3p shuttled by BALF-exo negatively regulated the expression of STK39 in NR8383 cells. BALF-exo loaded with miR-223-3p mimics also reduced lung injuries in ALI mice. In conclusion, miR-223-3p loaded in BALF-exo alleviates ALI by targeting STK39 in alveolar macrophages.

Indexed as

Acute Lung InjuryExosomesMicroRNAsAnimalsAutophagyBronchoalveolar Lavage FluidInflammationLipopolysaccharidesMacrophages, AlveolarMiceRatsLipopolysaccharidesMicroRNAsMIRN223 microRNA, mouseMIRN223 microRNA, ratAcute lung injuryAlveolar macrophageAutophagyBronchoalveolar lavage fluidExosomeInflammationmiR-223-3pSerine/threonine kinase 39

Identifiers

PMID35932362
OpenAlexW4290072633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.